# What does research show about ARA-290 for age-related cognitive decline?

Canonical source: https://retacompare.com/research/what-does-research-show-about-ara-290-for-age-related-cognitive-decline

Peptide Longevity Q&A · 2016-01-01


    ARA-290, also known as MK-X, demonstrates neuroprotective effects against neuronal death caused by oxidative stress. It activates ERK1/2 and Akt pathways, suggesting potential benefits for age-related cognitive decline without inducing cellular proliferation, making it a candidate for neuroprotective therapy.

 What the research shows

The study focused on the neuroprotective effects of ARA-290, a peptide derived from erythropoietin (EPO), in a cellular model of oxidative stress using PC1 2 cells. Researchers observed that ARA-290 ameliorated neuronal death induced by reactive oxygen species. The peptide was found to activate the ERK1/2 and Akt signaling pathways, which are crucial for cell survival. Inhibition of these pathways negated the neuroprotective effects of ARA-290, indicating the importance of these signaling routes in its mechanism of action. Unlike EPO, ARA-290 did not promote cellular proliferation, suggesting a distinct mode of action.

 Why it matters for longevity

The findings of this research are significant in the context of age-related cognitive decline and neuroprotection. As individuals age, oxidative stress contributes to neuronal damage and cognitive impairment. By demonstrating the ability to protect neurons from oxidative stress, ARA-290 may offer a therapeutic avenue to mitigate cognitive decline associated with aging. The activation of key survival pathways like ERK1/2 and Akt further underscores its potential role in enhancing neuronal resilience, which is vital for maintaining cognitive function in older adults. This research may pave the way for future studies exploring ARA-290 as a neuroprotective agent in various neurological disorders.

 Key findings at a glance

ARA-290 (MK-X) protects neurons from oxidative stress-induced death.

It activates ERK1/2 and Akt signaling pathways.

Inhibition of these pathways abolishes the neuroprotective effects.

ARA-290 does not induce cellular proliferation, differing from EPO.

The peptide may be a novel candidate for neuroprotective therapy.

 How ARA-290 works (background)

ARA-290 is a peptide derived from erythropoietin, a hormone known for its role in red blood cell production. In this study, ARA-290 mimics the weak binding site of EPO to its receptor, allowing it to exert neuroprotective effects without promoting cell proliferation. The activation of ERK1/2 and Akt pathways is crucial for cell survival, particularly under conditions of oxidative stress, which is prevalent in aging and neurodegenerative diseases. By targeting these pathways, ARA-290 may enhance neuronal survival and function, presenting a promising approach in the context of cognitive health and longevity.

 Safety, caveats, and what we don't yet know

While the study provides valuable insights into the neuroprotective effects of ARA-290, it is important to note that the research is preclinical and conducted in cell models. The safety profile of ARA-290 in human populations has not yet been established, and further studies are needed to assess its efficacy and safety in various neurological conditions. Additionally, the long-term effects of ARA-290 on cognitive function and overall healthspan remain to be determined. Research into its potential applications and mechanisms in human subjects is essential for translating these findings into clinical practice.

 Bottom line

ARA-290 shows promise as a neuroprotective agent against age-related cognitive decline by mitigating oxidative stress and activating survival pathways in neurons. Further research is required to fully understand its therapeutic potential.

 Related questions

 Can ARA-290 improve cognitive function in older adults?

Research indicates that ARA-290 may protect neurons from oxidative stress, which is linked to cognitive decline, suggesting potential benefits for cognitive function in older adults.

 How does oxidative stress affect aging?

Oxidative stress contributes to cellular damage and dysfunction, playing a significant role in the aging process and the development of age-related diseases, including neurodegenerative disorders.

 What are the potential applications of ARA-290 in neurodegenerative diseases?

Given its neuroprotective properties, ARA-290 may have potential applications in treating neurodegenerative diseases by protecting neurons from oxidative damage and promoting cell survival.

 Source: PubMed · CNS Neurol Disord Drug Targets · published 2016-01-01.

## Sources

- PubMed · CNS Neurol Disord Drug Targets: https://pubmed.ncbi.nlm.nih.gov/27875960/